Friday, January 13, 2017

Australian Drug Maker Has Low Profile but Powerful Backers in Washington by KATIE THOMAS


By KATIE THOMAS

Representatives Chris Collins and Tom Price and other power players have substantial investments in Innate Immunotherapeutics, a company with no approved drugs.

Published: January 12, 2017 at 07:00PM

from NYT Health http://ift.tt/2jhORMb
via IFTTT




from WordPress http://ift.tt/2in2omx
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)